Association between time to stent dysfunction and the anti-tumour effect of systemic chemotherapy following stent placement in patients with pancreaticobiliary cancers and malignan... by Satoshi Kobayashi, Makoto Ueno, Shuhei Nagashima, Yusuke Sano, Kuniyuki Kawano, Taito Fukushima, Hiroyuki Asama, Shun Tezuka, Manabu Morimoto

Get full text

FOLFOX regimen after failure of fluorouracil and leucovorin plus nanoliposomal-irinotecan therapy for advanced pancreatic cancer: a retrospective observational study by Satoshi Kobayashi, Shun Tezuka, Yui Yamachika, Shotaro Tsunoda, Shuhei Nagashima, Yuichiro Tozuka, Taito Fukushima, Manabu Morimoto, Makoto Ueno, Junji Furuse, Shin Maeda

Get full text

Modified FOLFIRINOX versus sequential chemotherapy (FOLFIRI/FOLFOX) as a second‐line treatment regimen for unresectable pancreatic cancer: A real‐world analysis by Shun Tezuka, Makoto Ueno, Ritsuko Oishi, Shuhei Nagashima, Yusuke Sano, Kuniyuki Kawano, Satoshi Tanaka, Taito Fukushima, Hiroyuki Asama, Naoki Konno, Satoshi Kobayashi, Manabu Morimoto, Shin Maeda

Get full text

Clinical outcome of a highly flexible duodenal stent for gastric outlet obstruction: A multicenter prospective study by Haruo Miwa, Kazuya Sugimori, Takashi Kaneko, Tomohiro Ishii, Shigeru Iwase, Kuniyasu Irie, Katsuyuki Sanga, Yuichiro Tozuka, Akane Hirotani, Satoshi Komiyama, Takeshi Sato, Shun Tezuka, Yoshihiro Goda, Kazushi Numata, Shin Maeda

Get full text